ResearchAndMarkets.com has added a report about North America’s legal cannabis industry to its offering. The report is titled “North America Cannabis: New Markets, Competitors and Opportunities: 2018-2026 Analysis and Forecasts.”

Outlined in the report is a breadth of information pertaining to North America’s rapidly evolving market. Data from the report is gleaned from legal and illicit cannabis-related activity throughout the U.S. and Canada.

North America’s legal cannabis industry is beneficial for all

By the year 2023, North America’s legal cannabis market will be worth an estimated US$ 35 Billion; indicating a definitive end to 80 years of pot prohibition. The rebirth of cannabis provides medical institutions and patients with an opportunity to get medicated, all the while providing tobacco and alcohol consumers with an option to use the green plant as a substitute. Furthermore, the growth of North America’s legal cannabis market provides investors with a chance to capitalize on the rise of legal weed.

The following companies are featured in the report about North America’s legal cannabis market:

• ABcann Global Corporation
• Aphria Inc
• Aurora Cannabis Inc.
• CannaRoyalty Corp
• Canopy Growth Corp.
• Cronos Group Inc.
• MedReleaf Corp.
• The Hydropothecary Corporation

Included in the report about North America’s cannabis industry are the following areas of information:

• Size and growth of the North America cannabis industry.
• Price trends and rival avenues for North America’s cannabis industry, such as the black market.
• Size and growth of the U.S. cannabis industry, including prices, market drivers and regulation issues.
• The change from illicit to legal cannabis in the U.S., including legal risks, tax incentives, financing issues, branding, threats/opportunities to other industries, derivative products, state metrics and characteristics, user base, etc.
• Market size and growth of Canada’s cannabis industry, including regulation issues, country metrics, prices, black market info, comparisons with the U.S., supply issues, production capacity and market potential.
• Specific company profiles, such as brands, facilities, prices, exports, facilities, product offerings, operations, sales, distribution, plant yields, patients, strategies, competitive advantages, etc.

Based on the research contained in this report, cannabis is increasing in popularity across North America for both medical and recreational purposes. It reveals some fascinating insights into the blossoming industry, from the key players and major distribution channels to the most popular cannabis products featured in today’s market.

With further research and development, more medical cannabis jobs will be created in North America, where the industry is expected to grow at a CAGR of 27.1 percent. The same can be said for North America’s recreational weed market, which will go into effect in Canada this October.

Find out more about North America’s cannabis industry by checking out the report here.